|
Contribution of extragonadal steroids to the androgen receptor activity and to the castration-resistance development in recurrent prostate cancers after primary therapy. |
|
|
Honoraria - Amgen Astellas BioPharma; Bayer; Janssen; Sanofi |
Consulting or Advisory Role - Amgen Astellas BioPharma; Bayer; Janssen; Progenics; Sanofi |
Speakers' Bureau - Amgen Astellas BioPharma; Bayer; Sanofi |
Research Funding - Astellas Amgen BioPharama; Bayer; Sanofi |
Expert Testimony - Amgen Astellas BioPharma; Bayer; Sanofi |
Travel, Accommodations, Expenses - Bayer; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Astellas Amgen BioPharama; Janssen |
|
|
Leadership - miR Scientific |
Honoraria - Amgen; Bayer; Exact imaging; Ferring; Profound Medical; Sanofi |
Research Funding - Exact Imaging; Ferring |
Expert Testimony - Profound Medical |
Travel, Accommodations, Expenses - TerSera |
|
|
No Relationships to Disclose |